logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Venkat Rami Reddy Macherla

This inventor holds 8 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Nereus Pharmaceuticals, Inc., Sirenas LLC, University of California. Active years: 2011-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Venkat Rami Reddy Macherla. Retrieved from https://idiyas.com/inventor/venkat-rami-reddy-macherla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 50.0

 

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:

goldMedal4 out of 36 
 
Nereus Pharmaceuticals, Inc.
 patents
silverMedal3 out of 4 
 
Sirenas LLC
 patents
bronzeMedal2 out of 16,058 
 
University of California
 patents
4. 1 out of 834,659 
Other
 patents
where one patent can have more than one assignee

Years Active: 2011-2024

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 12077606 - Cyclic peptide analogs and conjugates thereof (2024-09-03),
2. 11254705 - Cyclic peptide analogs and conjugates thereof (2022-02-22),
3. 10472395 - Cyclic peptide analogs and conjugates thereof (2019-11-12),
4. 8389564 - Proteasome inhibitors (2013-03-05),
5. 8227503 - Proteasome inhibitors (2012-07-24),
6. 8133915 - Interleukin-1 and tumor necrosis factor-α modulators; syntheses of such modulators and methods of using such modulators (2012-03-13),
7. 7910616 - Proteasome inhibitors (2011-03-22),
8. 7893299 - Interleukin-1 and tumor necrosis factor-αmodulators; syntheses of such modulators and methods of using such modulators (2011-02-22),

Title: Innovations by Venkat Rami Reddy Macherla: Pioneer in Cyclic Peptide Research

Introduction: Venkat Rami Reddy Macherla is an accomplished inventor based in San Diego, California, known for his significant contributions to the field of cyclic peptides and their applications in cancer treatment. With a remarkable portfolio of 8 patents, Macherla continues to push the boundaries of pharmaceutical innovation.

Latest Patents: Among his notable inventions are patents related to cyclic peptide analogs and conjugates. These patented compounds have shown promising potential in developing pharmaceutical compositions aimed at treating cancer. The innovative methods and compositions outlined in his patents focus on leveraging cyclic peptide structures to advance therapeutic options in oncology.

Career Highlights: Venkat Rami Reddy Macherla has cultivated an impressive career in pharmaceutical research, having worked with notable companies such as Nereus Pharmaceuticals, Inc. and Sirenas LLC. His work in these organizations has been instrumental in driving forward the development of novel therapeutic agents.

Collaborations: Macherla has collaborated with distinguished colleagues, including Ta-Hsiang Chao and Barbara Christine Potts. Through these partnerships, he has been able to enhance his research efficacy and broaden the impact of his innovations in the medical field.

Conclusion: Venkat Rami Reddy Macherla stands out as a prolific inventor in the field of cyclic peptides, with a focus on tackling complex diseases like cancer. His contributions, marked by a series of influential patents, exemplify the vital role of innovative research in advancing medical treatments and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…